FDA Warns Leukemia Patients that Blood Disorder Could Result from Taking Idhifa (Enasidenib) The U.S. Food and Drug Administration (FDA) issued an urgent warning to Leukemia patients prescribed Idhifa. The FDA communication released on November 29, 2018, indicates that Idhifa patients are at a higher risk of suffering from a blood … [Read more...]